Stock HEALTH NIGHTINGALE HEALTH OYJ
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Nightingale Health Oyj

Equities

HEALTH

FI4000490875

Market Closed - Nasdaq Helsinki
Other stock markets
 11:24:18 2024-04-30 am EDT 		5-day change 1st Jan Change
1.79 EUR +0.28% Intraday chart for Nightingale Health Oyj +5.29% +60.39%
Apr. 16 Finland’s Nightingale Health Plots US Expansion MT
Apr. 16 Nightingale Health to Establish A Laboratory in the United States CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Finland’s Nightingale Health Plots US Expansion
MT
Nightingale Health to Establish A Laboratory in the United States
CI
Nightingale Health and the Englander Institute for Precision Medicine At Weill Cornell Medicine Sign A Letter of Intent in Which the Parties Agree to Collaborate on the Adoption of Nightingale Health's Proprietary Technology in Healthcare and Medical Research in the United States
CI
Nightingale Health Secures Blood Analysis Contract with Kaiser Foundation
MT
Nightingale Health Enters into Agreement to Analyze 50,000 Blood Samples with Kaiser Foundation Health Plan, Inc
CI
Nightingale Health Closes Purchase of Japan's Welltus
MT
Nightingale Health Oyj completed the acquisition of Welltus Inc from Mitsui & Co., Ltd. and Kirin Holdings Company, Limited.
CI
Nightingale Health plc Enters into an Agreement in Which It Will Analyze Blood Samples from Uganda's General Population Cohort
CI
Finland-based Nightingale Health to Buy Japan's Welltus
MT
Nightingale Health Oyj Reports Earnings Results for the Half Year Ended December 30, 2023
CI
Nightingale Health Oyj agreed to acquire Welltus Inc from Mitsui & Co., Ltd. and Kirin Holdings Company, Limited.
CI
Nightingale Health Lands Five New Health Risk Detection Patents in Finland
MT
Nightingale Health plc Receives Five New Patents for Its Proprietary Health Risk Detection Capability
CI
Suomen Terveystalo Begins Using Nightingale Health's Blood Analysis Technology in Regular Health Checks in Occupational Health
CI
Terveystalo Integrates Nightingale Health's Blood Analysis Technology in Occupational Health
MT
Nightingale Health Completes the Analysis of All 500,000 UK Biobank Samples Creating the Largest Blood Biomarker Database for Chronic Disease Research and Prevention
CI
Nightingale Health and Innoquest Diagnostics Enter into Collaboration Agreement to Make Nightingale Health's Technology Accessible in the Southeast Asia Region
CI
Nightingale Health Oyj Reports Earnings Results for the Full Year Ended June 30, 2023
CI
Nightingale Health Secures Three New Patents in Finland
MT
Nightingale Health Receives Three New Patents Further Strengthening Its IP Portfolio
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HEALTH Stock
  4. News Nightingale Health Oyj
  5. Highlights